Immunovant, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2024 | 12.54 M | $357.45 M | 19.59% | 8.56% |
| VANGUARD GROUP INC | 11/13/2024 | 6.66 M | $189.84 M | 2.29% | 4.55% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 5.05 M | $144.07 M | 100.00% | 3.45% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 4.35 M | $123.95 M | 50.76% | 2.97% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 3.55 M | $101.15 M | 4.45% | 2.42% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 3.33 M | $94.97 M | 104.96% | 2.27% |
| STATE STREET CORP | 11/14/2024 | 3.02 M | $86.17 M | 11.16% | 2.06% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 2.38 M | $67.82 M | 23.65% | 1.62% |
| VIKING GLOBAL INVESTORS LP | 11/14/2024 | 2.32 M | $66.17 M | 0.00% | 1.58% |
| ALPINE GLOBAL MANAGEMENT, LLC | 11/14/2024 | 1.88 M | $53.68 M | -1.31% | 1.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.51 M | $43.09 M | 6.85% | 1.03% |
| WOODLINE PARTNERS LP | 11/14/2024 | 1.41 M | $40.34 M | -22.40% | 0.97% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 1.36 M | $38.85 M | 0.00% | 0.93% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.23 M | $35.08 M | 4.72% | 0.84% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 1.23 M | $34.94 M | 163.69% | 0.84% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.22 M | $34.82 M | 3.01% | 0.83% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.21 M | $34.47 M | -11.21% | 0.83% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.14 M | $32.60 M | 100.00% | 0.78% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.13 M | $32.26 M | 137.48% | 0.77% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 1.10 M | $31.50 M | -3.49% | 0.75% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 1.10 M | $31.36 M | 91.30% | 0.75% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 1.05 M | $30.90 M | -4.74% | 0.72% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2024 | 976,237 | $27.83 M | 0.00% | 0.67% |
| PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 951,124 | $27.12 M | 69.94% | 0.65% |
| BOXER CAPITAL, LLC | 11/14/2024 | 825,000 | $23.52 M | 0.00% | 0.56% |
| MORGAN STANLEY | 11/14/2024 | 817,742 | $23.31 M | 0.09% | 0.56% |
| TWO SEAS CAPITAL LP | 11/14/2024 | 676,614 | $19.29 M | -2.28% | 0.46% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 671,001 | $19.13 M | -33.69% | 0.46% |
| REDMILE GROUP, LLC | 11/14/2024 | 642,229 | $18.31 M | -10.82% | 0.44% |
| INVESCO LTD. | 11/12/2024 | 594,242 | $16.94 M | 4.09% | 0.41% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 580,000 | $16.54 M | 100.00% | 0.40% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 552,430 | $15.75 M | 19.79% | 0.38% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 521,673 | $14.87 M | 26.64% | 0.36% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 500,000 | $14.26 M | 49,900.00% | 0.34% |
| ABRDN PLC | 10/25/2024 | 478,757 | $13.65 M | 19.47% | 0.33% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 462,210 | $13.18 M | -6.57% | 0.32% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 376,507 | $10.73 M | 36.74% | 0.26% |
| PROSIGHT MANAGEMENT, LP | 11/14/2024 | 370,000 | $10.55 M | 13.85% | 0.25% |
| CITADEL ADVISORS LLC | 11/14/2024 | 339,921 | $9.69 M | -1.05% | 0.23% |
| VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 335,360 | $9.56 M | 7.36% | 0.23% |
| JANE STREET GROUP, LLC | 11/15/2024 | 324,165 | $9.24 M | 131.02% | 0.22% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 300,000 | $8.55 M | -28.57% | 0.20% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 294,200 | $8.39 M | 135.36% | 0.20% |
| TYRO CAPITAL MANAGEMENT LLC | 12/06/2024 | 252,149 | $7.19 M | 0.61% | 0.17% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 251,492 | $7.17 M | 43.55% | 0.17% |
| EMERALD ADVISERS, LLC | 10/29/2024 | 250,039 | $7.13 M | -13.35% | 0.17% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 243,000 | $6.93 M | 86.21% | 0.17% |
| JPMORGAN CHASE & CO | 12/26/2024 | 228,257 | $6.51 M | -11.13% | 0.16% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 227,024 | $6.47 M | -6.70% | 0.16% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 225,000 | $6.41 M | -34.99% | 0.15% |
Immunovant, Inc.institutional Ownership - FAQ's
During the previous two years, 228 institutional investors and hedge funds held shares of Immunovant, Inc.. The most heavily invested institutionals were:
FMR LLC: 12.54 M
VANGUARD GROUP INC: 6.66 M
BlackRock Funding, Inc. /DE: 5.05 M
Deep Track Capital, LP: 4.35 M
ARMISTICE CAPITAL, LLC: 3.55 M
T. Rowe Price Investment Management, Inc.: 3.33 M
53.69% of Immunovant, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 85.86 M shares in the last 24 months. This purchase volume represents approximately $2.10 B in transactions.